1-14 of 14
rosiglitazone
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High Peroxisome Proliferator-Activated Receptor-Gamma (PPARγ) Transcriptional Activity Reduces Active Influx of Imatinib and Kinase Inhibition in CML Cells

Jueqiong WANG, PhD, Chung Hoow Kok, PhD, Tamara M Leclercq, PhD, Verity A Saunders, BSc (Hons), Richard J D'Andrea, PhD, Timothy P. Hughes, MD MBBS, FRACP, FRCPA, Deborah L White, PhD FFSc (RCPA)
Journal: Blood
Blood (2015) 126 (23): 2770.
https://doi.org/10.1182/blood.V126.23.2770.2770
Published: 2015
Journal Articles

Long-Term Treatment with Rosiglitazone Delays Hematopoietic Recovery in Response to Stress

Wenyi Lu, Kaiyan Liu, Weimin Wang, Shujuan Wang, Yonghuai Feng
Journal: Blood
Blood (2015) 126 (23): 4769.
https://doi.org/10.1182/blood.V126.23.4769.4769
Published: 2015
Journal Articles

PPAR-γ Agonists Induce Growth Arrest of Kit/AML1-ETO Leukemia Cells Acting on Diverse Pathways

Valter Agosti, MD PhD, Daniela Talarico, Agostina Urzino, Raghavendra Vasudeva Murthi, PhD, Aurora Anna Rita Nocera, PhD, Emilia Dora Giovannone
Journal: Blood
Blood (2014) 124 (21): 5211.
https://doi.org/10.1182/blood.V124.21.5211.5211
Published: 2014
Journal Articles

Role Of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) and Its Ligands In The Regulation Of Functional OCT-1 Activity In CML Cells

Jueqiong Wang, PhD, Chung Hoow Kok, PhD, Richard J. D'Andrea, PhD, Timothy P. Hughes, MD, MBBS, Deborah L. White, PhD, FFSc(RCPA)
Journal: Blood
Blood (2013) 122 (21): 1470.
https://doi.org/10.1182/blood.V122.21.1470.1470
Published: 2013
Journal Articles

Quantitative trait mapping reveals a regulatory axis involving peroxisome proliferator-activated receptors, PRDM16, transforming growth factor-β2 and FLT3 in hematopoiesis

Serine Avagyan, Francesca Aguilo, Kenjiro Kamezaki, Hans-Willem Snoeck
Journal: Blood
Blood (2011) 118 (23): 6078–6086.
https://doi.org/10.1182/blood-2011-07-365080
Published: 2011
Includes: Supplemental data
Journal Articles

The Scd1 Gene Functions as a Tumor Suppressor In Leukemia Stem Cells

Haojian Zhang, Shaoguang Li, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 201.
https://doi.org/10.1182/blood.V116.21.201.201
Published: 2010
Journal Articles

Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas

Aadra P. Bhatt, Prasanna M. Bhende, Sang-Hoon Sin, Debasmita Roy, Dirk P. Dittmer, Blossom Damania
Journal: Blood
Blood (2010) 115 (22): 4455–4463.
https://doi.org/10.1182/blood-2009-10-251082
Published: 2010
Includes: Supplemental data
Journal Articles

Human Myeloma Cells Undergo Differentiation and Apoptosis upon Exposure of Rosiglitazone and All-Trans Retinoic Acid Via Apoptosis Signaling Pathway Modulation

Haiwen Huang, Wu Depei, Guanghua Chen, Weirong Chang, Anska Y.H. Leung, Raymond Liang, Howard C.H. Chow
Journal: Blood
Blood (2008) 112 (11): 5045.
https://doi.org/10.1182/blood.V112.11.5045.5045
Published: 2008
Journal Articles

Gene Expression Analysis of Bexarotene Differentiated Acute Myeloid Leukemias Identifies Known and Novel Gene Targets.

Patricia Vanessa Sanchez, PhD, Reid P Bissonnette, PhD, Donald E Tsai, MD, PhD, Martin Carroll, MD
Journal: Blood
Blood (2008) 112 (11): 1199.
https://doi.org/10.1182/blood.V112.11.1199.1199
Published: 2008
Journal Articles

Patients with Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (HR-MDS) Treated with Targeted Therapy May Benefit from Prophylactic Measures Against Infections.

Gloria N. Mattiuzzi, MD, Jorge E. Cortes, MD, Stefan Faderl, MD, Maria E. Cabanillas, MD, Francis J. Giles, MD, Susan O’Brien, MD, Guillermo Garcia-Manero, MD, Hagop H. Kantarjian, MD
Journal: Blood
Blood (2006) 108 (11): 4483.
https://doi.org/10.1182/blood.V108.11.4483.4483
Published: 2006
Journal Articles

PPARγagonist Inhibited the Expression of β-Catenin in Rabbit Abdominal Aortic Artery Atherosclerotic Plaque with Hypercholesterolemia.

Miao Jiang, MD, Yulin Wang, B.M, Xia Bai, M.D, Changgeng Ruan
Journal: Blood
Blood (2006) 108 (11): 3931.
https://doi.org/10.1182/blood.V108.11.3931.3931
Published: 2006
Journal Articles

Ex Vivo Anti-Tumor Activity of Rosiglitazone on Multiple Myeloma Cells.

Haiwen Huang, MD, De Pei Wu, MD, Anskar Y.H. Leung, MD, Raymond Liang, MD, Albert K.W. Lie, MD
Journal: Blood
Blood (2006) 108 (11): 5052.
https://doi.org/10.1182/blood.V108.11.5052.5052
Published: 2006
Journal Articles

Study of the Combination of Bortezomib with PPAR/RXR Agonists Rosiglitazone and Bexarotene in Lymphoproliferative Disorder-Derived Cell Linesγ.

Ellen Friday, Gang Ye, Francesco Turturro
Journal: Blood
Blood (2005) 106 (11): 4427.
https://doi.org/10.1182/blood.V106.11.4427.4427
Published: 2005
Journal Articles

Induction of Apoptosis in Multiple Myeloma by Ligands of Peroxisome Proliferator-Activated Receptor γ (PPAR-γ).

Jan Eucker, MD, Katharina Baengeroth, Ivana Zavrski, MD, Holger Krebbel, Chuanbing Zang, PhD, Ulrike Heider, MD, Christian Jakob, MD, Elena Elstner, PhD, Kurt Possinger, MD, Orhan Sezer, MD
Journal: Blood
Blood (2004) 104 (11): 4848.
https://doi.org/10.1182/blood.V104.11.4848.4848
Published: 2004